AnHeart Therapeutics
AnHeart Therapeutics is an orally available small molecule founded in 2018 by Lihua Zheng.
Seedtable Score
40
Startups
1
Funding Rounds
$61.0m
Money raised
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company AnHeart Therapeutics has raised a total of $61m in funding over 1 rounds.
Key Insights:
- AnHeart Therapeutics Series B round, December 2021: $61m
AnHeart Therapeutics Series B round, December 2021
$61m
Industries
AnHeart Therapeutics is active in the following industries: